Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nils Schoof

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Maturitas|August 29, 2024
Real-world evaluation of treatment utilization by women experiencing vasomotor symptoms associated with menopause in the United States and Europe: Findings from the REALISE studySheryl Kingsberg, Victoria Banks, Cecilia Caetano, et al.
Climacteric : the Journal of the International Menopause Society|May 2, 2024
Real-world clinical evaluation of natural and induced vasomotor symptoms in the USA and EuropeSheryl Kingsberg, Victoria Banks, Cecilia Caetano, et al.
Maturitas|July 26, 2024
Treatment utilization and non-drug interventions for vasomotor symptoms in breast cancer survivors taking endocrine therapy: Real-world findings from the United States and EuropeSheryl Kingsberg, Victoria Banks, Cecilia Caetano, et al.
The Patient|July 12, 2025
Exit Interviews Examining Changes to Mood and Work/Productivity Impacts Related to Vasomotor Symptoms: Perspectives of Postmenopausal Women Receiving Elinzanetant in Phase III Clinical TrialsClaudia Haberland, Melissa Barclay, Asha Lehane, et al.
Journal of Patient-Reported Outcomes|July 1, 2025
Qualitative exploration of women's experiences of vasomotor symptoms to support the content validity of patient-reported outcomesClaudia Haberland, Melissa Barclay, Sophie Whyman, et al.
Arthritis Research & Therapy|January 11, 2022
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysisMichael Kreuter, Francesco Del Galdo, Corinna Miede, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2012
Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphomaChristina Heemann, Markus Kreuz, Irene Stoller, et al.
The Oncologist|January 10, 2013
Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphomaNils Schoof, Jeremy Franklin, Robert Fürst, et al.
Menopause (New York, N.Y.)|November 5, 2025
The burden of sleep disturbances on quality of life and mental well-being in nearly 50,000 perimenopausal and postmenopausal women with and without concurrent vasomotor symptoms from the United States and EuropeClaudio N Soares, Paula Briggs, Carina Dinkel-Keuthage, et al.
Journal of Neuroimmunology|July 14, 2023
Treatment with sofosbuvir attenuates the adverse neurodevelopmental consequences of Zika virus infection in infant rhesus macaquesAlejandra Medina, Rebecca Rusnak, Rebecca Richardson, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Maturitas|August 29, 2024
Real-world evaluation of treatment utilization by women experiencing vasomotor symptoms associated with menopause in the United States and Europe: Findings from the REALISE studySheryl Kingsberg, Victoria Banks, Cecilia Caetano, et al.
Climacteric : the Journal of the International Menopause Society|May 2, 2024
Real-world clinical evaluation of natural and induced vasomotor symptoms in the USA and EuropeSheryl Kingsberg, Victoria Banks, Cecilia Caetano, et al.
Maturitas|July 26, 2024
Treatment utilization and non-drug interventions for vasomotor symptoms in breast cancer survivors taking endocrine therapy: Real-world findings from the United States and EuropeSheryl Kingsberg, Victoria Banks, Cecilia Caetano, et al.
The Patient|July 12, 2025
Exit Interviews Examining Changes to Mood and Work/Productivity Impacts Related to Vasomotor Symptoms: Perspectives of Postmenopausal Women Receiving Elinzanetant in Phase III Clinical TrialsClaudia Haberland, Melissa Barclay, Asha Lehane, et al.
Journal of Patient-Reported Outcomes|July 1, 2025
Qualitative exploration of women's experiences of vasomotor symptoms to support the content validity of patient-reported outcomesClaudia Haberland, Melissa Barclay, Sophie Whyman, et al.
Arthritis Research & Therapy|January 11, 2022
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysisMichael Kreuter, Francesco Del Galdo, Corinna Miede, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2012
Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphomaChristina Heemann, Markus Kreuz, Irene Stoller, et al.
The Oncologist|January 10, 2013
Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphomaNils Schoof, Jeremy Franklin, Robert Fürst, et al.
Menopause (New York, N.Y.)|November 5, 2025
The burden of sleep disturbances on quality of life and mental well-being in nearly 50,000 perimenopausal and postmenopausal women with and without concurrent vasomotor symptoms from the United States and EuropeClaudio N Soares, Paula Briggs, Carina Dinkel-Keuthage, et al.
Journal of Neuroimmunology|July 14, 2023
Treatment with sofosbuvir attenuates the adverse neurodevelopmental consequences of Zika virus infection in infant rhesus macaquesAlejandra Medina, Rebecca Rusnak, Rebecca Richardson, et al.
Pageof 6